Company intelligence / Profile preview

Cameco

Saskatoon, Saskatchewan, Canadacameco.com ↗

Ownership: Private
Employees: ~2000
Development stage: Commercial

Overview

Cameco is a Canadian multinational corporation specializing in uranium mining and the provision of nuclear fuel products to power utilities globally. While it plays an important role supplying cobalt‑60 isotopes used by pharmaceutical companies for device sterilization and some cancer therapies through partnerships with Nordion/Bruce Power, it does not operate as a biotech/pharma/life science/drug development company nor does it have any clinical pipeline or therapeutic programs. Its primary business focus remains energy/nuclear materials rather than healthcare innovation or pharmaceuticals.

Industry: Chemicals & Materials

Partnerships

Nordion and Bruce Power for the supply of medical isotopes such as Cobalt-60 used in healthcare sterilization and cancer treatment

Beyond the preview

Go deeper on Cameco.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cameco.

Explore the full profile